Renal prostaglandin E2 in nephrogenic diabetes insipidus: Effects of inhibition of prostaglandin synthesis by indomethacin
- 30 September 1980
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 97 (3), 476-478
- https://doi.org/10.1016/s0022-3476(80)80211-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin.JCI Insight, 1977
- Validity of PG E1 radioimmunoassay by using PG E1 antisera with differential binding parametersFEBS Letters, 1975
- Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney.JCI Insight, 1975
- A simple direct assay for cyclic amp in plasma and other biological samples using an improved competitive protein binding techniqueClinica Chimica Acta; International Journal of Clinical Chemistry, 1974
- Redistribution of renal cortical blood flow during inhibition of prostaglandin synthesisAmerican Journal of Physiology-Legacy Content, 1974
- Demonstration of a Defect in the Formation of Adenosine 3′, 5′-Monophosphate in Vasopressin-resistant Diabetes InsipidusPediatric Research, 1974
- Effects of vasopressin and prostaglandin E1 on the adenyl cyclase—cyclic 3′,5′-adenosine monophosphate system of the renal medulla of the ratJCI Insight, 1971
- Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3′,5′-monophosphate, and theophyllineJCI Insight, 1968